Biophore India Pharmaceuticals
Biophore’s portfolio spread across 30 therapeutic segments, is specialized in development and manufacture of pharmaceutical actives for Oncology medications, Contrast and Diagnostic media.
For updated list of products, send an email to email@example.com
Meet us at
CPHI Middle East & Africa 20183 - 5 September 2018 Abu Dhabi, UAE Visit us at stand J50 Book a meeting See our Exhibitor Profile
Our Top products
Regadenoson is an A2A adenosine receptor agonist that is a coronary vasodilator that is commonly used in pharmacologic stress testing. It produces hyperemia quickly and maintains it for a duration that is useful for radionuclide myocardial perfusion imaging. The selective nature of the drug makes it pref...More info
Biophore's API : DMF Available
Isoprenaline (INN) or isoproterenol (USAN) (trade names Medihaler-Iso and Isuprel) is a medication used for the treatment of bradycardia (slow heart rate), heart block, and rarely for asthma. In humans, it is a non-selective β adrenoreceptor agonist and TAAR1 agonist ...
News about Biophore India Pharmaceuticals
26 Jan 2017
DCAT 2017 - New York
Meet Biophore Team at the upcoming DCAT Meeting in New York City on March 20th- 23th 2017!Walk-in to our suite in The Kimberly.
17 Nov 2016
Biophore sets up a new central Research & Development laboratory
Biophore, a fast-growing pharmaceutical company involved in development and manufacturing niche generic APIs, sets up a new central Research & Development laboratory in Hyderabad, India. This facility will significantly boost Biophore’ s capabilities and complement its research activities.Read more
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation